Evidence map›Paper›PMID 24096643›Full record

ReviewActa pharmacologica Sinica2013

Hydrogen sulfide and translational medicine.

Wei Guo, Ze-Yu Cheng, Yi-Zhun Zhu

Open access · hybridAbstract readReview
In one paragraph

Review in Acta pharmacologica Sinica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Targeted HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Targeted HBiomaterials research · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Hydrogen Sulfide Biology and Its Role in Cancer.Molecules (Basel, Switzerland) · 2022
    Review
  11. TNFα regulates the expression of the CSE gene in HUVEC.Experimental and therapeutic medicine · 2021
    Article
  12. Basic Pharmacological Characterization of EV-34, a New HMolecules (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. The Role of Host-Generated HFrontiers in cellular and infection microbiology · 2020
    Review
  20. Sustained Release of Hydrogen Sulfide (HAnnals of biomedical engineering · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Wei GuoDepartment of Pharmacology, School of Pharmacy, Shanghai 201203, China.
Ze-Yu Cheng
Yi-Zhun Zhu
Shanghai Business School · CNNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen sulfide (H2S) along with carbon monoxide and nitric oxide is an important signaling molecule that has undergone large numbers of fundamental investigations. H2S is involved in various physiological activities associated with the regulation of homeostasis, vascular contractility, pro- and anti-inflammatory activities, as well as pro- and anti-apoptotic activities etc. However, the actions of H2S are influenced by its concentration, reaction time, and cell/disease types. Therefore, H2S is a signaling molecule without definite effect. The use of existing H2S donors is limited because of the instant release and short lifetime of H2S. Thus, translational medicine involving the sustained and controlled release of H2S is of great value for both scientific and clinical uses. H2S donation can be manipulated by different ways, including where H2S is given, how H2S is donated, or the specific structures of H2S-releasing drugs and H2S donor molecules. This review briefly summarizes recent progress in research on the physiological and pathological functions of H2S and H2S-releasing drugs, and suggests hope for future investigations.

Indexed as

Drug DesignTranslational Research, BiomedicalAnimalsApoptosisHomeostasisHumansHydrogen SulfideInflammationSignal TransductionHydrogen Sulfide

Identifiers

PMID24096643
PMCPMC3791558
OpenAlexW2014515422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.